OculomeX Names Moh Thudor Chief Executive Officer to Lead the Global Evolution of AI-Powered Health Prevention
OculomeX has appointed Moh Thudor as Chief Executive Officer, effective 1 March 2026, to lead the company in expanding its AI-powered platform for cardiovascular health prevention globally. The platform uses retinal imaging to provide insights into heart health, aiming to integrate seamlessly into healthcare practices. This move is significant as it represents a shift towards proactive health prevention and involves partnerships with academic and industry leaders to transform global healthcare a
Read disclosure →